Mitovesicles secreted into the extracellular space of brains with mitochondrial dysfunction impair synaptic plasticity

Pasquale D’Acunzo,Elentina K. Argyrousi,Jonathan M. Ungania,Yohan Kim,Steven DeRosa,Monika Pawlik,Chris N. Goulbourne,Ottavio Arancio,Efrat Levy

DOI: https://doi.org/10.1186/s13024-024-00721-z

2024-04-17

Molecular Neurodegeneration

Abstract:Hypometabolism tied to mitochondrial dysfunction occurs in the aging brain and in neurodegenerative disorders, including in Alzheimer's disease, in Down syndrome, and in mouse models of these conditions. We have previously shown that mitovesicles, small extracellular vesicles (EVs) of mitochondrial origin, are altered in content and abundance in multiple brain conditions characterized by mitochondrial dysfunction. However, given their recent discovery, it is yet to be explored what mitovesicles regulate and modify, both under physiological conditions and in the diseased brain. In this study, we investigated the effects of mitovesicles on synaptic function, and the molecular players involved.

neurosciences

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the role of mitochondria-derived small extracellular vesicles (mitovesicles) in neurodegenerative diseases, particularly how they affect synaptic function. Specifically, the researchers focus on whether and how these mitovesicles impair long-term potentiation (LTP) in the hippocampus of a Down syndrome (DS) mouse model, a form of neural plasticity closely related to learning and memory formation. Additionally, the study investigates the role of monoamine oxidase B (MAO-B) in this impairment, as MAO-B is a key enzyme in mitovesicles known to be associated with neurodegenerative diseases.

Through this study, the authors aim to reveal new mechanisms of mitovesicles in the pathological propagation of neurodegenerative diseases and provide new perspectives on the molecular basis of synaptic dysfunction in these diseases. This not only helps to deepen the understanding of Down syndrome and its related neurodegenerative lesions but also potentially provides a theoretical basis for developing new therapeutic strategies.